Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9314
0.033.49%
At close: -
$0.8849
-0.05-4.99%
After Hours: 4:01 PM EDT
Comments
Loading...
Estrella Immunopharma Analyst Ratings and Price Targets | NASDAQ:ESLA | Benzinga
Estrella Immunopharma Inc has a consensus price target of $16 based on the ratings of 1 analysts. The high is $16 issued by D. Boral Capital on June 3, 2025. The low is $16 issued by D. Boral Capital on June 3, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on June 3, 2025, May 29, 2025, and February 21, 2025, respectively. With an average price target of $16 between D. Boral Capital, there's an implied 1708.11% upside for Estrella Immunopharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
1calculated from analyst ratings
Analyst Ratings for Estrella Immunopharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/03/2025 | Buy Now | 1708.11% | D. Boral Capital | Jason Kolbert54% | $16 → $16 | Maintains | Buy | Get Alert |
| 05/29/2025 | Buy Now | 1708.11% | D. Boral Capital | Jason Kolbert54% | $16 → $16 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 1708.11% | D. Boral Capital | Jason Kolbert54% | $16 → $16 | Maintains | Buy | Get Alert |
| 02/18/2025 | Buy Now | 1708.11% | D. Boral Capital | Jason Kolbert54% | → $16 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Estrella Immunopharma (ESLA) stock?
The latest price target for Estrella Immunopharma (NASDAQ:ESLA) was reported by D. Boral Capital on June 3, 2025. The analyst firm set a price target for $16.00 expecting ESLA to rise to within 12 months (a possible 1708.11% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Estrella Immunopharma (ESLA)?
The latest analyst rating for Estrella Immunopharma (NASDAQ:ESLA) was provided by D. Boral Capital, and Estrella Immunopharma maintained their buy rating.
When was the last upgrade for Estrella Immunopharma (ESLA)?
There is no last upgrade for Estrella Immunopharma
When was the last downgrade for Estrella Immunopharma (ESLA)?
There is no last downgrade for Estrella Immunopharma.
When is the next analyst rating going to be posted or updated for Estrella Immunopharma (ESLA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Estrella Immunopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Estrella Immunopharma was filed on June 3, 2025 so you should expect the next rating to be made available sometime around June 3, 2026.
Is the Analyst Rating Estrella Immunopharma (ESLA) correct?
While ratings are subjective and will change, the latest Estrella Immunopharma (ESLA) rating was a maintained with a price target of $16.00 to $16.00. The current price Estrella Immunopharma (ESLA) is trading at is $0.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
